Prevention of perinatal hepatitis B virus transmission in the Netherlands, 2003-2007: Children of Chinese mothers are at increased risk of breakthrough infection

Vaccine

Volumn 30, Issue 9, 2012, Pages 1715-1720

  Hahné, Susan ^a   van den Hoek, Anneke ^b,c   Baayen, Dorothé ^b   van der Sande, Marianne ^a,d   de Melker, Hester ^a   Boot, Hein ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Hepatitis B immunoglobulin; Hepatitis B vaccine; Hepatitis B virus; Perinatal transmission; Vaccination

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

ANTIBODY TITER; ARTICLE; CHINESE; HEPATITIS B; HUMAN; INFANT; MAJOR CLINICAL STUDY; NETHERLANDS; PERINATAL INFECTION; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; VACCINATION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, PASSIVE; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; NETHERLANDS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS;

EID: 84856769937     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.071     Document Type: Article

References (32)

1. Hahné S.J., de Melker H.E., Kretzschmar M., Mollema L., van der Klis F.R., van der Sande M.A., Boot H.J. Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007. Epidemiol Infect 2011, [Epub ahead of print].
2. Marschall T., Kretzschmar M.E.E., Mangen M.J., Schalm S. High impact of migration on the prevalence of chronic hepatitis B in the Netherlands. Eur J Gastroenterol Hepatol 2008, 20:1214-1225.
3. Dutch Ministry of Health Welfare and Sport, 22.7.2010. Infants to be vaccinated against hepatitis B. Internet communication; 2010 Available from (accessed 08.10.10). http://www.rijksoverheid.nl/nieuws/2010/07/22/baby-s-ook-ingeent-tegen-hepatitis-b.html.
4. Edmunds W.J., Medley G.F., Nokes D.J., Hall A.J., Whittle H.C. The influence of age on the development of the hepatitis B carrier state. Proc R Soc Lond B: Biol Sci 1993, 253:197-201.
5. Lee C., Gong Y., Brok J., Boxall E.H., Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006, 332:328-336.
6. Marion S.A., Tomm P.M., Pi D.W., Mathias R.G. Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. Am J Epidemiol 1994, 140:734-746.
7. World Health Organisation Hepatitis B vaccines. Weekly Epidemiol Record 2009, 84:405-420.
8. van der Ploeg C, Toll D, Oomen P, Op de Coul E, Hahné S. Procesmonitoring prenatale screening infectieziekten en erytrocytenimmunisatie 2005-2007. TNO Reports 2008. Report no KvL/P&Z/2008.036.
9. Op de Coul E.L., Hahné S., van Weert Y.W., Oomen P., Smit C., van der Ploeg K.P., Notermans D.W., Boer K., van der Sande M.A. Antenatal screening for HIV, hepatitis B and syphilis in the Netherlands is effective. BMC Infect Dis 2011, 11:185.
10. van Steenbergen J.E., Leentvaar-Kuijpers A., Baayen D., Dukers H.T., van Doornum G.J., van den Hoek J.A., et al. Evaluation of the hepatitis B antenatal screening and neonatal immunization program in Amsterdam, 1993-1998. Vaccine 2001, 20:7-11.
11. Health Council of the Netherlands. Vaccination of children against hepatitis B. The Hague: Health Council of the Netherlands; 2003; Report no. 2003/14.
12. del Canho R., Grosheide P.M., Mazel J.A., Heijtink R.A., Hop W.C., Gerards L.J., et al. Ten-year neonatal hepatitis B vaccination program. The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997, 15(15):1624-1630.
13. Health Council of the Netherlands. General vaccination against hepatitis B revisited. The Hague, Health Council of the Netherlands; 2009; Report no. 2008/03E.
14. Boot H.J., Cremer J., Koedijk F., Ballegooijen M. Op de Coul ELM. Improved tracing of hepatitis B virus transmission chains by phylogenetic analysis based on C region sequences. J Med Virol 2008, 80:233-241.
15. STATA 10 Statistical Data Analysis Software 2008, Statacorp, Lakeway Drive College Station, Texas.
16. Boot H.J., Hahné S., Cremer J., Wong A., Boland G., van Loon A.M. Persistent and transient hepatitis-B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination. J Viral Hepat 2009, 17:872-878.
17. Giraudon I., Permalloo N., Nixon G., Charlett A., Cohuet S., Mandal S., et al. Factors associated with incomplete vaccination of babies at risk of perinatal hepatitis B transmission: a London study in 2006. Vaccine 2009, 27:2016-2022.
18. Heininger U., Vaudaux B., Nidecker M., Pfister R.E., Posfay-Barbe K.M., Bachofner M., et al. Evaluation of the compliance with recommended procedures in newborns exposed to HBsAg-positive mothers: a multicenter collaborative study. Pediatr Infect Dis J 2010, 29:248-250.
19. van Lier EA, Oomen PJ, Zwakhals SLN, Drijfhout IH, de Hoogh PAAM, de Melker H. Immunization coverage National Immunization Programme in the Netherlands; RIVM Reports 2010. Report no 210021011/2010.
20. Ramsay M. Policy on the use of passive immunisation with hepatitis b immunoglobulin (HBIg) for infants born to hepatitis b infected mothers; 2008. Available from (accessed 8.12.10). http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1223019399138.
21. Araujo N.M., Waizbort R., Kay A. Hepatitis B virus infection from an evolutionary point of view: How viral, host, and environmental factors shape genotypes and subgenotypes. Infect Genet Evol 2011, 11:1199-1207.
22. Chu C.J., Hussain M., Lok A.S. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002, 122:1756-1762.
23. Ngui S.L., Andrews N.J., Underhill G.S., Heptonstall J., Teo C.G. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998, 27:100-106.
24. Wang Z., Zhang J., Yang H., Li X., Wen S., Guo Y., et al. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol 2003, 71:360-366.
25. Jorgensen P., Poethko-Muller C., Hellenbrand W., Jilg W., Thierfelder W., Meyer C., et al. Low hepatitis B immunogenicity of a hexavalent vaccine widely used in Germany: results of the German Health Survey for Children and Adolescents, 2003-2006. Epidemiol Infect 2010, 138:1621-1629.
26. Sloan D., Ramsay M., Prasad L., Gelb D., Teo C.G. Prevention of perinatal transmission of hepatitis B to babies at high risk: an evaluation. Vaccine 2005, 23:5500-5508.
27. Euler G.L., Copeland J.R., Rangel M.C., Williams W.W. Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women. Pediatr Infect Dis J 2003, 22:123-129.
28. van Zonneveld M., van Nunen A.B., Niesters H.G., de Man R.A., Schalm S.W., Janssen H.L. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003, 10:294-297.
29. Buster E.H., van Erpecum K.J., Schalm S.W., Zaaijer H.L., Brouwer J.T., Gelderblom H.C., et al. Treatment of chronic hepatitis B virus infection - Dutch national guidelines. Neth J Med 2008, 66:292-306.
30. Boland G.J., Veldhuijzen I.K., Janssen H.L., van der Eijk A.A., Wouters M.G., Boot H.J. Management and treatment of pregnant women with hepatitis B. Ned Tijdschr Geneeskd 2009, 153:A905.
31. van der Ploeg C, Schönbeck Y. Hepatitis B-immunisation of infants born to HBV-infected mothers: TNO Reports 2006. Report no KvL/P&Z 2006.057.
32. van der Ploeg C.P., Kateman H., Vermeer-de Bondt P.E., Verkerk P.H. Increased risk of hepatitis B due to incomplete or untimely immunisation in one-quarter of infants of hepatitis-B-virus carriers. Ned Tijdschr Geneeskd 2004, 148:1820-1824.